Literature DB >> 15850657

Macrophages and neurodegeneration.

Jerome J A Hendriks1, Charlotte E Teunissen, Helga E de Vries, Christine D Dijkstra.   

Abstract

Multiple sclerosis (MS) is a chronic inflammatory demyelinating disease of the central nervous system (CNS). Demyelination is a classical feature of MS lesions, and neurological deficits are often ascribed to the reduced signal conduction by demyelinated axons. However, recent studies emphasize that axonal loss is an important factor in MS pathogenesis and disease progression. Axonal loss is found in association with cellular infiltrates in MS lesions. In this review, we discuss the possible contribution of the innate immune system in this process. In particular, we describe how infiltrated macrophages may contribute to axonal loss in MS and in experimental autoimmune encephalomyelitis (EAE), the animal model for MS. An overview is given of the possible effects of mediators, which are produced by activated macrophages, such as such as pro-inflammatory cytokines, free radicals, glutamate and metalloproteases, on axonal integrity. We conclude that infiltrated macrophages, which are activated to produce pro-inflammatory mediators, may be interesting targets for therapeutic approaches aimed to prevent or reduce axonal loss during exacerbation of inflammation. Interference with the process of infiltration and migration of monocytes across the blood-brain barrier is one of the possibilities to reduce the damage by activated macrophages.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15850657     DOI: 10.1016/j.brainresrev.2004.12.008

Source DB:  PubMed          Journal:  Brain Res Brain Res Rev


  75 in total

Review 1.  Aquaporin 4 and neuromyelitis optica.

Authors:  Marios C Papadopoulos; A S Verkman
Journal:  Lancet Neurol       Date:  2012-05-16       Impact factor: 44.182

Review 2.  CNS immune privilege: hiding in plain sight.

Authors:  Monica J Carson; Jonathan M Doose; Benoit Melchior; Christoph D Schmid; Corinne C Ploix
Journal:  Immunol Rev       Date:  2006-10       Impact factor: 12.988

3.  Preoperative mucosal tolerance to brain antigens and a neuroprotective immune response following surgical brain injury.

Authors:  Robert E Ayer; Nazanin Jafarian; Wanqiu Chen; Richard L Applegate; Austin R T Colohan; John H Zhang
Journal:  J Neurosurg       Date:  2011-10-21       Impact factor: 5.115

Review 4.  α9-containing nicotinic acetylcholine receptors and the modulation of pain.

Authors:  Arik J Hone; Denis Servent; J Michael McIntosh
Journal:  Br J Pharmacol       Date:  2017-07-30       Impact factor: 8.739

5.  Genomic characterization of Japanese macaque rhadinovirus, a novel herpesvirus isolated from a nonhuman primate with a spontaneous inflammatory demyelinating disease.

Authors:  Ryan D Estep; Scott G Hansen; Kelsey S Rogers; Michael K Axthelm; Scott W Wong
Journal:  J Virol       Date:  2012-10-24       Impact factor: 5.103

6.  Central neuroinvasion and demyelination by inflammatory macrophages after peripheral virus infection is controlled by SHP-1.

Authors:  George P Christophi; Paul T Massa
Journal:  Viral Immunol       Date:  2009-12       Impact factor: 2.257

7.  Modulation of macrophage infiltration and inflammatory activity by the phosphatase SHP-1 in virus-induced demyelinating disease.

Authors:  George P Christophi; Chad A Hudson; Michael Panos; Ross C Gruber; Paul T Massa
Journal:  J Virol       Date:  2008-11-05       Impact factor: 5.103

Review 8.  Ceramide and ceramide 1-phosphate in health and disease.

Authors:  Lide Arana; Patricia Gangoiti; Alberto Ouro; Miguel Trueba; Antonio Gómez-Muñoz
Journal:  Lipids Health Dis       Date:  2010-02-05       Impact factor: 3.876

9.  Macrophages offer a paradigm switch for CNS delivery of therapeutic proteins.

Authors:  Natalia L Klyachko; Matthew J Haney; Yuling Zhao; Devika S Manickam; Vivek Mahajan; Poornima Suresh; Shawn D Hingtgen; R Lee Mosley; Howard E Gendelman; Alexander V Kabanov; Elena V Batrakova
Journal:  Nanomedicine (Lond)       Date:  2013-11-18       Impact factor: 5.307

10.  Macrophages of multiple sclerosis patients display deficient SHP-1 expression and enhanced inflammatory phenotype.

Authors:  George P Christophi; Michael Panos; Chad A Hudson; Rebecca L Christophi; Ross C Gruber; Akos T Mersich; Scott D Blystone; Burk Jubelt; Paul T Massa
Journal:  Lab Invest       Date:  2009-04-27       Impact factor: 5.662

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.